Department Of Gastroenterology And Hepatology 1

1. Global multi-societies endorsement of the MAFLD definition
2. Global multi-societies endorsement of the MAFLD definition
3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
4. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
5. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
6. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
7. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
8. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
9. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
10. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
11. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
12. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
13. A global action agenda for turning the tide on fatty liver disease
14. A global action agenda for turning the tide on fatty liver disease
15. A global action agenda for turning the tide on fatty liver disease
16. A global action agenda for turning the tide on fatty liver disease
17. Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study
18. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
19. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
20. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
21. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
22. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
23. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
24. The case for simplifying and using absolute targets for viral hepatitis elimination goals
25. The case for simplifying and using absolute targets for viral hepatitis elimination goals
26. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes
27. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project
28. Usage Behaviour and Adoption Criteria for Mobile Health Solutions in Patients with Chronic Diseases in Gastroenterology
1